What is it about?

Please see my explainer for version 2 of this article. The scientific content of the current version 3 is identical to that of version 2. The only differences involve correction of some details related to licensing. https://www.growkudos.com/publications/10.12688%25252Ff1000research.10624.2/author

Featured Image

Read the Original

This page is a summary of: Dose Titration Algorithm Tuning (DTAT) should supersede ‘the’ Maximum Tolerated Dose (MTD) in oncology dose-finding trials, F1000Research, July 2017, Faculty of 1000, Ltd.,
DOI: 10.12688/f1000research.10624.3.
You can read the full text:

Read
Open access logo

Contributors

The following have contributed to this page